ETF DAILY NEWS

Analysts Set Mersana Therapeutics, Inc. (NASDAQ:MRSN) Price Target at $4.25

Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The […]

Mar 16, 2025 - 06:33
 0
Analysts Set Mersana Therapeutics, Inc. (NASDAQ:MRSN) Price Target at $4.25
Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The […]
Read More

Tags:

Previous Article

Brokerages Set OceanaGold Co. (TSE:OGC) Target Price at C$5.58

Next Article

Brokerages Set Barrick Gold Co. (TSE:ABX) Target Price at C$30.73

Related Posts

Meta Platforms, Inc. (NASDAQ:META) Shares Bought by Holistic Planning LLC

Meta Platforms, Inc. (NASDAQ:META) Shares Bought by Hol...

Feb 10, 2025  0

Raymond James Cuts Automotive Properties Real Est Invt TR (TSE:APR.UN) Price Target to C$12.25

Raymond James Cuts Automotive Properties Real Est Invt ...

Mar 10, 2025  0

Ulta Beauty (NASDAQ:ULTA) Price Target Cut to $475.00 by Analysts at JPMorgan Chase & Co.

Ulta Beauty (NASDAQ:ULTA) Price Target Cut to $475.00 b...

Mar 15, 2025  0